Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,446,000 | 6,088,000 | 4,740,000 | 5,100,000 | 6,218,000 |
| Marketable Securities | 1,108,000 | 1,117,000 | 1,508,000 | 1,323,000 | 1,732,000 |
| Receivables | 4,891,000 | 4,859,000 | 4,677,000 | 4,758,000 | 4,999,000 |
| Inventories | 1,785,000 | 1,582,000 | 1,427,000 | 1,444,000 | 1,630,000 |
| TOTAL | $18,930,000 | $16,962,000 | $15,547,000 | $16,187,000 | $16,290,000 |
| Non-Current Assets | |||||
| PPE Net | 2,697,000 | 2,657,000 | 2,612,000 | 2,604,000 | 2,638,000 |
| Investments And Advances | 1,971,000 | 2,052,000 | 2,123,000 | 1,783,000 | 1,378,000 |
| Intangibles | 43,915,000 | 44,018,000 | 44,119,000 | 44,313,000 | 44,770,000 |
| Other Non-Current Assets | 1,327,000 | 1,305,000 | 1,263,000 | 1,212,000 | 1,550,000 |
| TOTAL | $49,910,000 | $50,032,000 | $50,117,000 | $49,912,000 | $50,336,000 |
| Total Assets | $68,840,000 | $66,994,000 | $65,664,000 | $66,099,000 | $66,626,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,821,000 | 3,420,000 | 425,000 | 402,000 | 26,000 |
| Accounts payable and accrued liabilities | 9,212,000 | 8,839,000 | 8,419,000 | 9,379,000 | 9,077,000 |
| TOTAL | $13,033,000 | $12,259,000 | $8,844,000 | $9,781,000 | $9,103,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 33,974,000 | 33,817,000 | 36,526,000 | 36,440,000 | 37,284,000 |
| Other Non-Current Liabilities | 8,999,000 | 8,518,000 | 8,499,000 | 8,352,000 | 7,646,000 |
| TOTAL | $49,120,000 | $48,726,000 | $51,822,000 | $51,682,000 | $51,054,000 |
| Total Liabilities | $62,153,000 | $60,985,000 | $60,666,000 | $61,463,000 | $60,157,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,596,430 | 1,594,095 | 1,591,540 | 1,593,920 | 1,625,099 |
| Common Shares | 18,000 | 18,000 | 18,000 | 18,000 | 18,000 |
| Retained earnings | 6,547,000 | 5,951,000 | 5,063,000 | 4,378,000 | 4,011,000 |
| Other shareholders' equity | -2,613,000 | -2,548,000 | -2,542,000 | -2,586,000 | -2,340,000 |
| TOTAL | $6,687,000 | $6,009,000 | $4,998,000 | $4,636,000 | $6,469,000 |
| Total Liabilities And Equity | $68,840,000 | $66,994,000 | $65,664,000 | $66,099,000 | $66,626,000 |